Express News | Nantahala Capital Management, LLC Reports 15.1% Passive Stake in Eagle Pharmaceuticals Inc as of June 30- SEC Filing
Express News | Shares of Eagle Pharmaceuticals Hit Session High of $5.13 in Volume Jump, Last up 9.9% at $5.00
Express News | Eagle Pharmaceuticals Inc Says on May 28, Co Requested Hearing Before Hearings Panel of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Express News | Eagle Pharmaceuticals Shares Are Trading Lower After the Company Announced a Nasdaq Listing Receipt
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersIGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDA
Express News | Eagle Pharmaceuticals Announces Receipt of Delisting Notification From Nasdaq
Eagle Pharmaceuticals Announces A Trial In Progress Presentation Of Phase 2/3 Study Of Intravenous Amisulpride As Prevention Of Postoperative Nausea And Vomiting In Pediatric Patients At The Upcoming Society For Ambulatory Anesthesia 2024 Annual Meeting
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today announced that it will deliver a Trial in Progress presentation discussing the ongoing Phase 2/3 study of intravenous amisulp
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks eased late Monday afternoon, with the NYSE Health Care Index decreasing 0.1% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. The iShares Biotechnology ETF (IBB) fell 1.
Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise
Eagle Pharmaceuticals (EGRX) shares climbed 9% in recent trading after the company said Monday that it will present phase III trial data showing that intravenous amisulpride may sustain an antiemetic
Express News | Eagle Pharmaceuticals To Present Additional Data From Phase 3 Trial Showing Sustained Response of Amisulpride For Rescue Treatment of Postoperative Nausea and Vomiting At Upcoming ASPAN 2024 National Conference
HROW, HCAT and EGRX Are Among After Hour Movers
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
Express News | Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency From Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency From Nasdaq Regarding Requirement to Timely File Annual Report On Form 10-K
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency From Nasdaq Regarding Requirement to Timely File Annual Report On Form 10-K.
Sector Update: Health Care
Health care stocks fell late Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both easing 0.1%, paring earlier losses. The iShares Biotechnology ETF (
Eagle Pharmaceuticals CFO Resigns; Shares Fall
Eagle Pharmaceuticals (EGRX) shares fell 6% in recent Monday trading after Brian Cahill resigned as chief financial officer on Friday, effective immediately. The company said in a regulatory filing th
Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes
Eagle Pharmaceuticals Announces Workforce Reduction
Eagle Pharmaceuticals Faces Nasdaq Delisting Deadline
Eagle Pharmaceuticals Updates Bendamustine IP Portfolio